Showing results (61-70 of 112) with videos related to
Sort By:
Pageof 12
Biochemical and Biophysical Research Communications|May 16, 1988
Comparison of binding affinities and calcium current inhibitory effects of a 1,4-dihydropyridine derivative (PN 200-110) in vascular smooth muscleC Dacquet, P Pacaud, G Loirand, et al.British Journal of Pharmacology|May 1, 1989
(+)-[3H]-PN 200-110 binding to cell membranes and intact strips of portal vein smooth muscle: characterization and modulation by membrane potential and divalent cationsC Dacquet, G Loirand, L Rakotoarisoa, et al.The American Journal of Physiology|July 17, 1999
Norepinephrine-induced Ca(2+) waves depend on InsP(3) and ryanodine receptor activation in vascular myocytesF X Boittin, N Macrez, G Halet, et al.The Journal of Biological Chemistry|February 21, 1997
Distinct functions of Gq and G11 proteins in coupling alpha1-adrenoreceptors to Ca2+ release and Ca2+ entry in rat portal vein myocytesN Macrez-Leprêtre, F Kalkbrenner, G Schultz, et al.Journal of Cellular and Molecular Medicine|August 9, 2002
Messenger molecules of the phospholipase signaling system have dual effects on vascular smooth muscle contractionCristina Vidulescu, J. Mironneau, Chantal Mironneau, et al.Pflugers Archiv : European Journal of Physiology|June 1, 1992
Calcium-dependence of the calcium-activated chloride current in smooth muscle cells of rat portal veinP Pacaud, G Loirand, G Grégoire, et al.Advances in Experimental Medicine and Biology|January 1, 1992
Potassium channel activation in vascular smooth muscleG Siegel, J Emden, K Wenzel, et al.Fundamental & Clinical Pharmacology|January 1, 1994
Effects of oxodipine and elgodipine on (+)-[3H]-isradipine binding to cardiac and vascular membranes: cardiovascular selectivityL Rakotoarisoa, N Leprêtre, J Mironneau, et al.British Journal of Pharmacology|December 1, 1991
Ca2+ channel activation and membrane depolarization mediated by Cl- channels in response to noradrenaline in vascular myocytesP Pacaud, G Loirand, A Baron, et al.British Journal of Pharmacology|September 1, 1990
Interactions of spironolactone with (+)-[3H]-isradipine and (-)-[3H]-desmethoxyverapamil binding sites in vascular smooth muscleJ Mironneau, I Sayet, L Rakotoarisoa, et al.Pageof 12